CAPTRUST FINANCIAL ADVISORS

Position in OCUL — Ocular Therapeutix, Inc

CIK 1512024 RALEIGH, NC

Position in OCUL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$124,095

+$76,370 QoQ

Shares Held

12,637

+9.9% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#192

of 257 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 48% Shared 0% None 52%

Healthcare · as of Jun 30, 2026

CAPTRUST FINANCIAL ADVISORS holds $167,360,822 across 124 Biotechnology names. OCUL ranks #83 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	36,464	$22,736,762
2	RPRX	Royalty Pharma plc	337,298	$18,912,298
3	VRTX	Vertex Pharmaceuticals Inc / Ma	35,471	$17,619,509
4	EXEL	Exelixis, Inc.	303,042	$16,488,515
5	LGND	Ligand Pharmaceuticals Inc	34,607	$10,938,926
6	HALO	Halozyme Therapeutics, Inc.	125,946	$9,857,793
7	CELC	Celcuity Inc.	71,445	$7,474,575
8	INCY	Incyte Corp	50,301	$5,702,121

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$124,095	12,637	+9.9%	Shares	Sole	2026-08-13
2022-09-30	$47,725	11,500	+9.5%	Shares	Sole	2022-11-16
2022-06-30	$42,210	10,500	+2000.0%	Shares	Sole	2022-08-23
2022-03-31	$2,475	500	0.0%	Shares	Sole	2022-05-16
2021-12-31	$3,485	500	0.0%	Shares	Sole	2022-02-14
2021-09-30	$5,000	500	0.0%	Shares	Sole	2021-11-16
2021-06-30	$7,090	500	0.0%	Shares	Sole	2021-08-16
2021-03-31	$8,205	500	0.0%	Shares	Sole	2021-05-17
2020-12-31	$10,350	500	0.0%	Shares	Sole	2021-02-16
2020-09-30	$3,805	500	0.0%	Shares	Sole	2020-11-17
2020-06-30	$4,165	500	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.